Results 151 to 160 of about 848,198 (341)
Micro/Nanorobots for Combating Brain Disorders: Challenges, Advances, and Perspectives
Micro/nanorobots (MNRs) offer a transformative approach for precision therapy in brain disorders. By overcoming biological barriers and enabling controlled propulsion, targeted delivery, and real‐time imaging/tracking, MNRs pave the way toward effective, minimally invasive treatments. This review outlines the interplay between brain disease challenges,
Qi Zhang, Dong Sun
wiley +1 more source
This multi‐institutional, randomized, phase II trial aimed to investigate the long‐term survival outcomes of two versus three courses of DCF for locally advanced esophageal squamous cell carcinoma (ESCC). The 5‐year overall survival and progression‐free survival rates for the three and two course groups were 70.7% vs. 63.8% (hazard ratio (HR) = 0.91, p
Takahito Sugase +19 more
wiley +1 more source
The aetiology behind odor-related chronic somatic symptoms (O-RCSS) is unknown, although both immunological and psychiatric causes have been suggested.
Hilde Gundersen +3 more
doaj
A preliminary communication on certain specific reactions exhibited by hay fever cases [PDF]
G. H. A. Clowes
openalex +1 more source
ABSTRACT Background Neoadjuvant chemotherapy (NAC) has been extensively developed for locally advanced gastric cancer (GC). In Asia, S‐1‐based regimens, such as docetaxel, oxaliplatin, and S‐1 (DOS) and S‐1 and oxaliplatin (SOX), are expected to become the standard of care.
Kota Kawabata +9 more
wiley +1 more source
Background: We previously reported that repeated low-dose grass pollen intradermal allergen injection suppresses allergen-induced cutaneous late-phase responses, comparable with conventional high-dose subcutaneous and sublingual immunotherapy. Objective:
Anna Slovick +13 more
doaj +1 more source
This study investigated the impacts of distance to transplant center on posttransplant survival following LDLT. Patients living further away from the transplant center had worse graft and patient survival rates than those of patients living closer, probably due to less frequency of follow‐up visits, and living > 40 miles from our treatment center was ...
Hajime Matsushima +9 more
wiley +1 more source
Louisville, Ky., Aug. 2. 1907. To the Editor: —I do not wish to stand in the position of exploiting new remedies, but the rather unfavorable comments on the new remedy "pollantin" in Dr. Curtis' paper inThe JournalJuly 13 prompts me to say a few words in regard to my experience with it. The first pollantin I used was obtained from Dr.
openaire +2 more sources

